Aug 2026· International Journal of Molecular Sciences· Vol 27, pp. 7235· 0 citations· 27 references
Medicine
TL;DR
Key structural features required for thiomuscimol-mediated inflammasome inhibition are identified and a framework for future studies to define its mechanism of action and guide the development of improved inhibitors is provided.
Abstract
Inflammasomes are central mediators of innate immune defense but can also drive pathological inflammation and pyroptotic cell death in numerous diseases. While several small-molecule inhibitors have been described, many selectively target individual inflammasomes or act through the adaptor protein ASC, leaving ASC-independent pathways unaffected. We previously identified thiomuscimol as a broad-spectrum inflammasome inhibitor that blocks both ASC-dependent and ASC-independent activation, although the structural basis for this activity remains unclear. Here, we examined the structure–activity relationship of thiomuscimol using related compounds and synthetic analogs. In primary macrophages, inflammasome activation and pyroptosis were assessed by live cell imaging of ASC speck formation, gasdermin D-mediated dye uptake, and cellular ATP levels. Structurally related sulfur-containing molecules, including taurine and isothiazole, failed to inhibit inflammasome activation, indicating that neither the sulfur in an electron-rich environment nor the heterocyclic scaffold confer activity. Replacement of the primary amine with a carbonyl group abolished activity, whereas substitution with a secondary amine preserved inhibitory potency comparable to thiomuscimol. Incorporation of the amine into an annulated piperidine ring reduced potency and revealed sensitivity to the precise positioning of the amine within the ring. Together, these findings identify key structural features required for thiomuscimol-mediated inflammasome inhibition and provide a framework for future studies to define its mechanism of action and guide the development of improved inhibitors.
This review systematically summarizes the molecular regulatory mechanisms of pyroptosis, encompassing classical and non-classical inflammasome pathways, activation and modulation of gasdermin proteins, and the intricate signaling networks involved.
Yi Shen, Qiang-Qiang Zheng, Yang Yuan et al.· Frontiers in Cell and Develo...· 0 citations
Findings provide a perspective for understanding the molecular regulatory process of the non-canonical inflammasome in sepsis and positively regulated the activation of the non-canonical inflammasome by inhibiting the activity of dipeptidyl peptidase 3.
Meng-Qian Li, Jia-Jia Zheng, Chun Kong et al.· Cell Chemical Biology· 0 citations
Emerging evidence now reveals that pyroptosis exhibits dual functionality through its capacity to reshape the tumor immune microenvironment, and the cytotoxicity and immunotherapeutic response rate of cytotoxic T cells are significantly enhanced by activation of the T cell receptor signaling pathway and cytokine networ...
Xiao-Han Zhang, Ke Zhang, Xue-Chun Qu et al.· Apoptosis· 0 citations
Inflammasomes ignite innate immune defense in response to infectious pathogens and noninfectious dangers, primarily through sensors composed of nucleotide-binding domain (NBD), leucine-rich repeat (LRR)-containing (NLR) family proteins. NLRP6 is an inflammasome sensor that plays critical roles in regulating intestinal...
Zhen Cui, Qi Sheng, Minsoo Son et al.· Nature Structural & Molecula...· 0 citations
The NLRP3 inflammasome plays a central role in innate immunity and inflammatory diseases, yet effective inhibitors remain limited. Here, we identified vilazodone, an FDA-approved antidepressant, as a potent inhibitor of NLRP3 inflammasome activation by small-molecule screening. Vilazodone significantly suppressed IL-1β...
Xiang-Yu Yang, Gui-Fang Xiong, Jie Yang et al.· International Immunopharmaco...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.